The global medical oxygen concentrators market size was valued at USD 1.54 billion in 2025 and is projected to grow from USD 1.68 billion in 2026 to USD 3.35 billion by 2034, registering a CAGR of 9.01% during the forecast period from 2026 to 2034. North America dominated the medical oxygen concentrators market with a market share of 38.5% in 2025.
Medical oxygen concentrators are electrically powered medical devices that extract oxygen from ambient air and deliver a concentrated supply of oxygen to patients requiring supplemental oxygen therapy. They use technologies such as molecular sieve adsorption to separate nitrogen from oxygen and provide continuous or pulse-dose oxygen delivery. These devices are commonly used in hospitals, clinics, emergency care, and home healthcare settings for patients with respiratory conditions.
Download a Free Sample To learn more about this report,
Increasing Adoption of Portable and Lightweight Oxygen Concentrators for Home-Based Respiratory Care
Demand is shifting toward compact and portable oxygen concentrators that support oxygen therapy outside traditional hospital settings. Lightweight designs, improved battery performance, and pulse-dose delivery are increasing patient mobility while supporting longer-term home-based respiratory care and reducing reliance on conventional oxygen cylinders.
Growing Integration of Smart Monitoring and Advanced Oxygen Delivery Technologies
Medical oxygen concentrators are increasingly incorporating intelligent oxygen sensing, automated flow adjustment, digital controls, and connectivity features. These capabilities can help personalize oxygen delivery, improve treatment monitoring, and support more efficient respiratory care while increasing the value of connected oxygen therapy devices.
Rising Prevalence of Chronic Respiratory Diseases Supports Medical Oxygen Concentrators Market Growth
The increasing burden of chronic respiratory conditions such as chronic obstructive pulmonary disease, asthma, and other disorders requiring supplemental oxygen is expanding the addressable patient population for oxygen concentrators. Growing demand for long-term respiratory support is encouraging healthcare providers and patients to adopt reliable oxygen therapy equipment for both institutional and home-based care.
High Costs of Advanced Oxygen Concentrator Technologies Can Limit Adoption
Advanced oxygen concentrators with enhanced portability, higher oxygen output, longer battery life, smart monitoring, and automated controls can carry higher acquisition and maintenance costs. These expenses can restrict adoption among price-sensitive patients and healthcare providers, particularly in markets where reimbursement coverage and homecare budgets remain limited.
Expansion of Home Healthcare and Remote Respiratory Monitoring Creates New Growth Opportunities
The expansion of home healthcare is creating opportunities for oxygen concentrators that combine oxygen delivery with digital monitoring and connected care capabilities. Integrating concentrators with remote patient management can help healthcare providers track therapy, support treatment adherence, and manage respiratory patients outside hospitals while improving continuity of care.
Maintaining Oxygen Concentration, Device Reliability, and Patient Safety Creates Technical Challenges
Oxygen concentrators must consistently deliver the required oxygen concentration and flow under different operating conditions while maintaining reliable performance during extended use. Battery limitations, component wear, alarm performance, maintenance requirements, and compliance with medical-device safety standards create technical challenges for manufacturers seeking to balance portability, performance, and reliability.
Portable Segment is Projected to Register the Fastest Growth at a CAGR of 7.65%
The portable segment is projected to register the fastest growth at a CAGR of 7.65% during 2026–2034. In 2025, the segment accounted for 57.6% of the global medical oxygen concentrators market, with a value of USD 0.89 billion. Growth is driven by increasing demand for convenient oxygen therapy, rising preference for home-based care, and the growing adoption of lightweight and easily transportable oxygen concentrators. Increasing prevalence of respiratory disorders and greater patient mobility continue to support the segment's growth.
The stationary segment continues to maintain a significant market presence owing to its high oxygen output capacity, reliable continuous operation, and widespread use in homecare and healthcare facilities. Its suitability for patients requiring long-duration oxygen therapy continues to support steady demand.
Request Customizationto receive a tailored report.
Pulse Flow Segment is Projected to Register the Fastest Growth at a CAGR of 7.75%
The pulse flow segment is projected to register the fastest growth at a CAGR of 7.75% during 2026–2034. In 2025, the segment accounted for 38.2% of the global medical oxygen concentrators market, with a value of USD 0.59 billion. Growth is driven by increasing demand for portable oxygen therapy, improved battery efficiency, and growing preference for oxygen delivery systems that support greater patient mobility. Technological advancements in compact oxygen concentrators continue to support the segment's growth.
The continuous flow segment dominated the market owing to its ability to provide a consistent supply of oxygen and its extensive use among patients requiring continuous oxygen therapy. Increasing adoption across hospitals and homecare settings, along with the growing prevalence of chronic respiratory diseases, continues to reinforce the segment's leading market position.
Home Care Settings Segment is Projected to Register the Fastest Growth at a CAGR of 7.55%
The home care settings segment is projected to register the fastest growth at a CAGR of 7.55% during 2026–2034. In 2025, the segment accounted for 49.3% of the global medical oxygen concentrators market, with a value of USD 0.76 billion. Growth is driven by increasing preference for home-based oxygen therapy, rising prevalence of chronic respiratory diseases, and growing demand for portable and user-friendly oxygen delivery solutions. Expanding home healthcare services and improvements in remote patient care continue to support the segment's growth.
The hospitals segment continues to maintain a significant market presence owing to the high demand for oxygen therapy among hospitalized patients, particularly those requiring respiratory support. Ambulatory surgical centers continue to witness steady demand due to increasing outpatient procedures and the need for reliable oxygen supply during perioperative care, while other end users contribute to market growth through specialized healthcare and long-term care applications.
Speak to an Analystto discuss market opportunities.
North America medical oxygen concentrators market accounted for 38.5% of the global market, reaching USD 0.59 billion in 2025, and is projected to grow at a CAGR of 6.45% during the forecast period. The market is driven by the increasing prevalence of respiratory disorders, rising demand for home-based oxygen therapy, growing geriatric population, and increasing adoption of portable oxygen concentrators. Continuous advancements in oxygen delivery technologies continue to support regional market growth.
The US market was valued at USD 0.50 billion in 2025, making it the largest contributor in North America. Increasing prevalence of chronic respiratory diseases, growing adoption of home healthcare, rising healthcare expenditure, and expanding demand for portable oxygen therapy solutions continue to drive market growth.
Canada's market reached USD 0.09 billion in 2025. Growing demand for home-based respiratory care, increasing healthcare investments, expanding adoption of portable medical devices, and rising awareness of oxygen therapy continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe medical oxygen concentrators market accounted for 27.2% of the global market, reaching USD 0.42 billion in 2025, and is projected to grow at a CAGR of 6.25% during the forecast period. Rising prevalence of respiratory diseases, increasing demand for home healthcare, expanding elderly population, and growing adoption of advanced oxygen therapy equipment continue to strengthen regional market growth. Healthcare infrastructure development and technological advancements further support market expansion.
The UK market was valued at USD 0.08 billion in 2025. Increasing demand for home oxygen therapy, growing respiratory disease burden, expanding healthcare services, and rising adoption of portable oxygen concentrators continue to support market growth.
Germany market accounted for USD 0.12 billion in 2025. Strong healthcare infrastructure, increasing adoption of home-based respiratory care, growing elderly population, and rising investments in advanced medical equipment continue to drive market expansion.
Asia Pacific medical oxygen concentrators market accounted for 22.8% of the global market, reaching USD 0.35 billion in 2025, and is projected to grow at a CAGR of 8.15% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of respiratory disorders, growing healthcare awareness, and expanding access to home-based oxygen therapy continue to accelerate regional market growth. Rising healthcare expenditure and increasing demand for portable medical devices further strengthen market expansion.
China's market accounted for USD 0.15 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing respiratory disease burden, growing adoption of home healthcare equipment, and rising investments in medical device manufacturing continue to drive market expansion.
Japan's market generated USD 0.06 billion in 2025. Increasing elderly population, growing prevalence of respiratory conditions, expanding home healthcare services, and rising demand for compact oxygen delivery systems continue to support market growth.
Latin America medical oxygen concentrators market accounted for 6.4% of the global market, reaching USD 0.10 billion in 2025, and is projected to grow at a CAGR of 6.7% during the forecast period. Increasing healthcare access, growing prevalence of respiratory diseases, expanding home healthcare services, and rising adoption of oxygen therapy equipment continue to support regional market growth.
Brazil market accounted for USD 0.06 billion in 2025. Increasing healthcare investments, growing demand for respiratory care, expanding access to home oxygen therapy, and rising adoption of portable medical equipment continue to support market expansion.
Middle East and Africa medical oxygen concentrators market accounted for 5.1% of the global market, totaling USD 0.08 billion in 2025, and is projected to grow at a CAGR of 6.55% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of respiratory diseases, expanding access to oxygen therapy, and rising demand for home-based medical care continue to support regional market growth.
The UAE market was valued at USD 0.02 billion in 2025. Increasing investments in advanced healthcare facilities, expanding home healthcare services, growing demand for respiratory care, and rising adoption of portable oxygen concentrators continue to drive market growth.
Africa's market reached USD 0.06 billion in 2025. Expanding healthcare access, increasing investments in medical infrastructure, growing awareness of oxygen therapy, and rising demand for affordable respiratory care equipment continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
We are featured on:
sales@straitsresearch.com